APA (7th ed.) Citation

Hofer, K. D., Scheinost, S., Ben‐Taarit, L., Hüllein, J., Walther, T., Putzker, K., . . . Lu, J. (2025). 114 | SYSTEMATIC INVESTIGATION OF DISEASE‐ AND GENOTYPE‐SPECIFIC VULNERABILITIES IN PRIMARY BLOOD CANCER USING HIGH‐THROUGHPUT EX VIVO DRUG SCREENING. Hematological oncology, 43, 1. https://doi.org/10.1002/hon.70093_114

Chicago Style (17th ed.) Citation

Hofer, K. D., et al. "114 | SYSTEMATIC INVESTIGATION OF DISEASE‐ AND GENOTYPE‐SPECIFIC VULNERABILITIES IN PRIMARY BLOOD CANCER USING HIGH‐THROUGHPUT EX VIVO DRUG SCREENING." Hematological Oncology 43 (2025): 1. https://doi.org/10.1002/hon.70093_114.

MLA (9th ed.) Citation

Hofer, K. D., et al. "114 | SYSTEMATIC INVESTIGATION OF DISEASE‐ AND GENOTYPE‐SPECIFIC VULNERABILITIES IN PRIMARY BLOOD CANCER USING HIGH‐THROUGHPUT EX VIVO DRUG SCREENING." Hematological Oncology, vol. 43, 2025, p. 1, https://doi.org/10.1002/hon.70093_114.